Bakri Balloon Plus Tranexamic Acid During Cesarean Delivery for Placenta Previa

• Status: Recruiting
• Trial end date: 2022-07-31
• Target enrollment: 0
• Participant gender: Female

Summary

Objective to investigate the effect of adjunctive intravenous tranexamic acid (TA) on blood loss during cesarean section (CS) in patients with placenta previa undergone Bakri balloon tamponade

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Aswan University Hospital
• Treatments: Tranexamic Acid

Criteria

Inclusion Criteria:

• women undergoing elective cesarean delivery for complete placenta previa which not respond uterotonic and simple hemostatic maneuvers like placental bed hemostatic sutures

Exclusion Criteria:

• patients with the high possibility of morbid adherent placenta

• those presented with severe antepartum hemorrhage

• Patients with cardiac, hepatic, renal, or thromboembolic disease;

• hypersensitivity or contraindications of use of tranexamic acid

• patient refuses to consent